Scroll To Top

European agency rejects Serostim

European agency rejects Serostim

The European Medicines Evaluations Agency on Monday announced that its scientific committee has rejected an application by Serono to market its anti-wasting drug Serostim to AIDS patients in Europe. The drug is approved for the treatment of AIDS-related wasting in the United States. In a statement, the agency said there was concern about the long-term safety of the medication and that long-term efficacy data also was lacking. Serostim is a recombinant human growth hormone that has been shown to increase muscle mass in those taking the medication.

Advocate Channel - Out100 StreamAdvocate Magazine - Gio Benitez

From our Sponsors

Most Popular

Latest Stories Editors